China’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanidatamab for biliary tract ...

A new NDA was submitted in January 2024, which the FDA did accept, and that was later converted into a priority review. An ...

Alvotech and UK-based Advanz Pharma sign agreement to commercialise three additional biosimilar candidates in Europe.

Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Astellas Pharma has signed an exclusive licensing agreement with Evopoint Biosciences for XNW27011, a CLDN18.2-targeting ...

In the race to decarbonize the global economy, advanced materials are no longer a luxury – they’re a necessity.

The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids ...

Phase III progression-free survival data were positive for first-line Braftovi in first-line combination therapy for mCRC.

PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.

Eton Pharmaceuticals’ NDA for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA ...

The US Centers for Disease Control and Prevention (CDC) is no longer recommending Covid-19 vaccines to healthy children and ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...